✕
Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Confused about any medicine? Just ask Practo AIFREE
50000+ health queries resolved in last month
Chat with Practo AI on Whatsapp
Not finding what you need? Ask Practo AI
FREE
Chat with Practo AI on Whatsapp
Description
Brilinta 60 Tablet contains Ticagrelor, which is a blood thinner medicine. It is used along with Aspirin to reduce the risk of heart attack or stroke (damage to your brain resulting from reduced/blocked blood supply) or if you have a history of acute coronary syndrome (conditions resulting from reduced blood flow to your heart). It works by preventing the formation of blood clots.
Brilinta 60 Tablet may cause common side effects such as bleeding, bruising, dizziness, skin rash and itching, blurred vision, etc. Consult your doctor if these symptoms persist or worsen.
Brilinta 60 Tablet should be taken exactly as directed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body.
Brilinta 60 Tablet should be avoided if you are allergic to it. Inform your doctor if you have pre-existing kidney or liver problems before beginning treatment with this medicine. Close evaluation with respect to your current medicines is necessary to avoid any undesired side effects. If you are pregnant or breastfeeding, or are planning a pregnancy, consult your doctor before taking this medication.
QUICK LINKS:
Substitutes
List of substitutes for Brilinta 60 Tablet
Side effects
Major & minor side effects for Brilinta 60 Tablet
Increased blood uric acid levels
Bleeding
Bruising
Headache
Dizziness
Constipation or diarrhoea
Indigestion
Nausea
Skin rash and itching
Joint pain and swelling
Lightheadedness
Blurred vision
Nose bleed
Uses of Brilinta 60 Tablet
What is it prescribed for?
Acute Coronary Syndrome
Acute Coronary Syndrome is a broad term referring to a range of conditions associated with a sudden, reduced blood flow to your heart. Brilinta 60 Tablet is used in combination with aspirin for the prevention of myocardial infarction (heart attack), stroke (damage to your brain resulting from reduced/blocked blood supply), or death after you have experienced an event of an acute coronary syndrome.
Concerns
Commonly asked questions
How long does it take for this medicine to take effect?
Brilinta 60 Tablet begins to show its effect within 30 minutes after intake.How long do the effects of this medicine last?
Brilinta 60 Tablet remains effective for an approximate duration of two to three days after intake.Is it safe to consume alcohol while taking this medicine?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.Is this a habit forming medicine?
No habit-forming tendencies have been reported with Brilinta 60 Tablet.Can this medicine be taken during pregnancy?
Due to a lack of safety and efficacy studies in pregnant women, the risk to your developing foetus due to Brilinta 60 Tablet is not known. This medicine is not recommended during pregnancy unless necessary. If you are pregnant, consult your doctor.Can this medicine be taken while breast-feeding?
It is not known whether Brilinta 60 Tablet passes into breastmilk. Hence this medicine is not recommended during breastfeeding unless necessary. If you are breastfeeding, consult your doctor.
Allergy
Avoid Brilinta 60 Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.
Active bleeding
Brilinta 60 Tablet is not recommended if you have active bleeding in your stomach/intestines or bleeding due to any other conditions due to the increased risk of worsening your condition.
Intracranial haemorrhage
Intracranial haemorrhage is a condition that causes bleeding within your brain. Brilinta 60 Tablet is not recommended if you have a history of intracranial haemorrhage due to the increased risk of worsening your condition.
Severe Hepatic impairment
Hepatic impairment is a condition with a loss of liver function. Brilinta 60 Tablet is metabolized and broken down by the liver and is not recommended if you have severe hepatic impairment due to the increased risk of severe side effects, resulting from the accumulation of this medicine in your body.
Warnings for special population
Pregnancy
Due to a lack of safety and efficacy studies in pregnant women, the risk to your developing foetus due to Brilinta 60 Tablet is not known. This medicine is not recommended during pregnancy unless necessary. If you are pregnant, consult your doctor.
Breast-feeding
It is not known whether Brilinta 60 Tablet passes into breastmilk. Hence this medicine is not recommended during breastfeeding unless necessary. If you are breastfeeding, consult your doctor.
General warnings
Other medicines
Brilinta 60 Tablet may interact with other medicines and cause undesired side effects. Hence, inform your doctor about your current medicines including any herbs and supplements before beginning treatment with this medicine.
Bleeding
Brilinta 60 Tablet may increase your risk for bleeding and should be used with caution if you had recent surgery, have a history of bleeding in your stomach/intestines, have pre-existing liver problems or if you are on treatment with certain medicines (e.g. non-steroidal anti-inflammatory drugs, oral anticoagulants, fibrinolytics) that may increase your risk of bleeding due to the increased risk of further worsening your condition.
Dyspnoea
Brilinta 60 Tablet may increase your risk of dyspnoea (shortness of breath). This risk is especially higher if you have a history of asthma/chronic obstructive pulmonary disease (lung problems that cause breathing difficulty) and hence caution is required.
Discontinuation of treatment
Discontinuation of treatment with Brilinta 60 Tablet may increase your risk of myocardial infarction (heart attack), stroke (damage to your brain resulting from reduced/blocked blood supply), or death. Hence it is recommended to continue using this medicine for the duration prescribed by your doctor.
Heart rhythm abnormalities
Brilinta 60 Tablet may increase your risk of an irregular heart rhythm. This risk is especially higher if you have pre-existing heart problems and hence caution is required. Your electrocardiogram and electrolyte levels need to be closely monitored for the assessment of heart function.
Use in Children
Brilinta 60 Tablet is not recommended for use in children below 18 years of age due to a lack of safety and efficacy studies.
Driving or Operating machines
Brilinta 60 Tablet may cause dizziness and blurred vision. If you experience any symptoms that may affect your mental alertness, do not drive vehicles or operate machines.
Surgery
If you are on treatment with Brilinta 60 Tablet, inform your doctor before planning surgery. Since Brilinta 60 Tablet may increase your risk of bleeding, it is recommended to discontinue treatment with this medicine at least 5 days before undergoing surgery. However, your doctor may suggest the appropriate time of withdrawal based on your clinical condition.
Increased creatinine levels
Brilinta 60 Tablet may cause an increase in creatinine levels. It is recommended to periodically monitor your kidney function after beginning treatment with this medicine.
Hyperuricaemia
Brilinta 60 Tablet may increase your risk of hyperuricaemia (high blood uric acid levels). This medicine should be used with caution if you have a history of hyperuricaemia or gouty arthritis (a type of arthritis resulting from the accumulation of uric acid crystals in joint spaces).
Thrombotic thrombocytopenic purpura
Brilinta 60 Tablet may increase your risk of thrombotic thrombocytopenic purpura, a rare condition that causes blood clots to form in small blood vessels throughout your body.
Missed Dose
Try not to skip a dose of Brilinta 60 Tablet. Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.
Overdose
Do not take more than the prescribed dose. Contact your doctor if you suspect an overdose with Brilinta 60 Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Atazanavir
Nefazodone
Dalteparin
Phenytoin
Carbamazepine
Mifepristone
Rifampicin
Apixaban
Phenobarbital
Ketoconazole
Clarithromycin
Disease interactions
Liver Disease
Brilinta 60 Tablet is metabolized and broken down by the liver and should be used with caution if you have pre-existing liver problems (moderate) due to the increased risk of undesired side effects, resulting from the accumulation of this medicine in your body. Your liver function needs to be closely monitored and dose adjustments may be required based on your clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Brilinta 60 Tablet with or without food. Do not take more or less than the prescribed dose. Do not stop the use of this medicine without consulting your doctor.
Brilinta 60 Tablet may increase your risk of bleeding. Inform your doctor if you experience any unusual bleeding or bruising, or have other signs and symptoms of bleeding such as red/black tarry stools, coughing up or vomiting blood, etc.
Brilinta 60 Tablet may cause an increase in your blood uric acid levels. Periodic monitoring of your uric acid levels is recommended.
Do not drive vehicles or operate machines if you experience any symptoms that may affect your alertness after taking Brilinta 60 Tablet.
Miscelleneous
How it works
Brilinta 60 Tablet belongs to a class of medicines called antiplatelets. It works by preventing platelets (a type of blood cell) from collecting and forming clots and thereby reduces the risk of a heart attack or a stroke (damage to your brain resulting from reduced/blocked blood supply).
Legal Status
Classification
Category
Platelet aggregation inhibitors
Schedule
Schedule H
Medicines.org.uk. 2021. Brilique 90 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 21 December 2021].
Medicines.org.uk. 2021. [online] Available at: < [Accessed 21 December 2021].
Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 21 December 2021].
Rad-ar.or.jp. 2021. Search results detail| Kusurino-Shiori(Drug information Sheet). [online] Available at: < [Accessed 21 December 2021].
Ebs.tga.gov.au. 2021. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: < [Accessed 21 December 2021].
Drugs, H., 2021. Ticagrelor: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 21 December 2021].
nhs.uk. 2021. Ticagrelor: an antiplatelet medicine to prevent blood clots. [online] Available at: < [Accessed 21 December 2021].
Related Questions
Question:
Is Brilinta (ticagrelor) an angioplasty medicine. With which other medicines does doctors recommend ...more
Answer from Dr Lt Col R P Singh (Retd)
It's the correct medicine
Question:
I m following my new prescription from today, in which doc replace Brilinta 90 with plavix. Should I...more
Answer from Dr. Vijay Kumar
U can continue plavix.
Question:
I m taking Brilinta 90 twice a day can it be possible to change with Axcer as I never try Axcer befo...more
Answer from Dr. Rajni Sharma
Both contain same salt only brand is different,can take
Question:
Had 3 stents in the month of December 2017. Have been taking brilinta 90 mg 2 times a day and ecospi...more
Answer from Dr. Pavankumar Rasalkar
Don’t decide on stopping antiplatelet s urself. Or else there will be stent thro...more
Question:
Substitute of Tenepla-M 500 & Euglim-M & Brilinta
Pls suggest me which tablets to give him in gener...more
Answer from Dr. Anand Parikh
Generics not recommended
Information on this page was last updated on 7 Feb 2022
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.
₹507.92
14 TABLET ( 14 / STRIP )